A Prospective, Non-interventional Cohort Study of Subsolid Pulmonary Nodules
NCT ID: NCT06458673
Last Updated: 2024-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
1184 participants
OBSERVATIONAL
2024-12-01
2030-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed subsolid pulmonary nodule by CT, initial pulmonary nodule ≥ 5 mm (including subsolid components) and ≤ 30 mm, do not shrink or disappear after 3 months Follow-up.
* ECOG 0～2
* Able to provide CT in DICOM format
* Informed consent obtained
Exclusion Criteria
* History of previous malignancy (if there is no recurrence or carcinoma in situ for more than 5 years after receiving curative therapy, it can be enrolled)
* Inability to cooperate with regular follow-up
* Poor general condition, with the life expectancy less than 6 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Third Affiliated Hospital, Sun Yat-Sen University
OTHER
Fifth Affiliated Hospital, Sun Yat-Sen University
OTHER
Peking University People's Hospital
OTHER
Guangxi Medical University
OTHER
Shanghai Zhongshan Hospital
OTHER
The Third Xiangya Hospital of Central South University
OTHER
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
OTHER
The Third People's Hospital of Chengdu
OTHER
Shantou Central Hospital
OTHER
Hainan Cancer Hospital
OTHER
Shenzhen People's Hospital
OTHER
Hunan Cancer Hospital
OTHER
Shenzhen Third People's Hospital
OTHER
First Affiliated Hospital of Jinan University
OTHER
Haikou People's Hospital
OTHER
Second Affiliated Hospital of Guangzhou Medical University
OTHER
Guangdong Provincial People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xue-Ning Yang
Vice-Chief of Guangdong Lung Cancer Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xuening Yang, MD
Role: PRINCIPAL_INVESTIGATOR
Guangdong Provincial People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CONAN
Identifier Type: -
Identifier Source: org_study_id